Episode 17: X4 Vs FX: New TAVR Transformations

Update: 2023-09-25

Description

Dr. George and the Columbia Valve team discussed new technology from the two largest structural heart companies, the Edwards SAPIEN X4 and the Medtronic Evolut FX.

Comments

In Channel

Episode 19: Transcatheter Tricuspid Valve Replacement - Insights from TCT 2023 Part 2

2024-01-0820:13

Episode 18: Low-risk TAVR Trials - Insights from TCT 2023 Part 1

2023-12-1820:56

Episode 17: X4 Vs FX: New TAVR Transformations

2023-09-2520:17

Episode 16: TVT 2023 Wrap-Up Part 2

2023-08-2816:23

Episode 15: TVT 2023 Wrap-Up Part 1

2023-07-3116:23

Episode 14: Left Atrial Appendage Closure

2021-05-1722:22

Episode 13: Current Transcatheter Tricuspid Valve Therapy Options And Trial Considerations

2021-04-2023:51

Episode 12: New Valve Guidelines Update - Secondary MR

2021-03-1521:22

Episode 11: New Valve Guidelines 2020 Updates - Primary MR

2021-02-1725:23

Episode 10: New Valve Guidelines 2020 Updates - Severe AS

2021-01-1423:55

Episode 9: Volume Outcomes Relationship in Medicine

2020-08-2520:57

Episode 8: Big Data

2020-08-1020:22

Episode 7: Structural Heart Trials and COVID: How Do We Move Forward?

2020-06-0117:51

Episode 6: New Procedural Requirements for TAVR

2020-05-2626:03

Episode 5: COVID and Structural Heart Training

2020-05-2619:13

Episode 4: M.A.C.

2019-05-1622:46

Episode 3: Low Risk Trials

2019-04-1523:28

Episode 2: Awake Vs Asleep

2019-03-1417:45

Episode 1: Valve Fracture

2019-03-1426:07

00:00

1.0x

Episode 17: X4 Vs FX: New TAVR Transformations

Columbia University Valve Center

#box-pro-ellipsis-176437501269237{-webkit-line-clamp:2;}Episode 17: X4 Vs FX: New TAVR Transformations

Episode 17: X4 Vs FX: New TAVR Transformations

Columbia University Valve Center

Episode 17: X4 Vs FX: New TAVR Transformations